Invention Grant
- Patent Title: Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer
-
Application No.: US14802077Application Date: 2015-07-17
-
Publication No.: US09855348B2Publication Date: 2018-01-02
- Inventor: Nick Devoogdt , Jens De Vos , Matthias D'Huyvetter , Tony Lahoutte
- Applicant: VRIJE UNIVERSITEIT BRUSSEL
- Applicant Address: BE Brussels
- Assignee: VRIJE UNIVERSITEIT BRUSSEL
- Current Assignee: VRIJE UNIVERSITEIT BRUSSEL
- Current Assignee Address: BE Brussels
- Agency: Lathrop Gage LLP
- Agent James H. Velema, Esq.
- Priority: EP14178943 20140729
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K51/10 ; C07K16/32 ; A61K9/00

Abstract:
The application provides polypeptides comprising or essentially consisting of at least one heavy chain variable domain of a heavy chain antibody (VHH) or functional fragments thereof, wherein said VHH or functional fragment thereof specifically binds to a target protein that is present on and/or specific for a solid tumor or cancer cell, e.g., HER2. The application further provides nucleic acids encoding such polypeptides; methods for preparing such polypeptides; host cells expressing or capable of expressing such polypeptides; compositions, and in particular to pharmaceutical compositions that comprise such polypeptides, nucleic acids and/or host cells. The application further provides such polypeptides, nucleic acids, host cells and/or compositions, for use in methods for the prevention and/or treatment of cancer.
Public/Granted literature
- US20160030606A1 RADIO-LABELLED ANTIBODY FRAGMENTS FOR USE IN THE PREVENTION AND/OR TREATMENT OF CANCER Public/Granted day:2016-02-04
Information query